227 related articles for article (PubMed ID: 23638056)
1. Fine mapping and functional analysis of the multiple sclerosis risk gene CD6.
Swaminathan B; Cuapio A; Alloza I; Matesanz F; Alcina A; García-Barcina M; Fedetz M; Fernández O; Lucas M; Orpez T; Pinto-Medel MJ; Otaegui D; Olascoaga J; Urcelay E; Ortiz MA; Arroyo R; Oksenberg JR; Antigüedad A; Tolosa E; Vandenbroeck K
PLoS One; 2013; 8(4):e62376. PubMed ID: 23638056
[TBL] [Abstract][Full Text] [Related]
2. The Link Between CD6 and Autoimmunity: Genetic and Cellular Associations.
Kofler DM; Farkas A; von Bergwelt-Baildon M; Hafler DA
Curr Drug Targets; 2016; 17(6):651-65. PubMed ID: 26844569
[TBL] [Abstract][Full Text] [Related]
3. The CD6 multiple sclerosis susceptibility allele is associated with alterations in CD4+ T cell proliferation.
Kofler DM; Severson CA; Mousissian N; De Jager PL; Hafler DA
J Immunol; 2011 Sep; 187(6):3286-91. PubMed ID: 21849685
[TBL] [Abstract][Full Text] [Related]
4. Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain.
Swaminathan B; Matesanz F; Cavanillas ML; Alloza I; Otaegui D; Olascoaga J; Cénit MC; de las Heras V; Barcina MG; Arroyo R; Alcina A; Fernandez O; Antigüedad A; Urcelay E; Vandenbroeck K
J Neuroimmunol; 2010 Jun; 223(1-2):100-3. PubMed ID: 20430450
[TBL] [Abstract][Full Text] [Related]
5. ALCAM and CD6--multiple sclerosis risk factors.
Wagner M; Bilinska M; Pokryszko-Dragan A; Sobczynski M; Cyrul M; Kusnierczyk P; Jasek M
J Neuroimmunol; 2014 Nov; 276(1-2):98-103. PubMed ID: 25216742
[TBL] [Abstract][Full Text] [Related]
6. Structures of CD6 and Its Ligand CD166 Give Insight into Their Interaction.
Chappell PE; Garner LI; Yan J; Metcalfe C; Hatherley D; Johnson S; Robinson CV; Lea SM; Brown MH
Structure; 2015 Aug; 23(8):1426-1436. PubMed ID: 26146185
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of CD6 and PD-1 Identifies Dysfunctional CD8
Enyindah-Asonye G; Nwankwo A; Rahman MA; Hunegnaw R; Hogge C; Helmold Hait S; Ko EJ; Hoang T; Robert-Guroff M
Front Immunol; 2019; 10():3005. PubMed ID: 31998302
[TBL] [Abstract][Full Text] [Related]
8. Associations of CD6, TNFRSF1A and IRF8 polymorphisms with risk of inflammatory demyelinating diseases.
Park TJ; Kim HJ; Kim JH; Bae JS; Cheong HS; Park BL; Shin HD
Neuropathol Appl Neurobiol; 2013 Aug; 39(5):519-30. PubMed ID: 22994200
[TBL] [Abstract][Full Text] [Related]
9. Extracellular isoforms of CD6 generated by alternative splicing regulate targeting of CD6 to the immunological synapse.
Castro MA; Oliveira MI; Nunes RJ; Fabre S; Barbosa R; Peixoto A; Brown MH; Parnes JR; Bismuth G; Moreira A; Rocha B; Carmo AM
J Immunol; 2007 Apr; 178(7):4351-61. PubMed ID: 17371992
[TBL] [Abstract][Full Text] [Related]
10. The genetic association of variants in CD6, TNFRSF1A and IRF8 to multiple sclerosis: a multicenter case-control study.
International Multiple Sclerosis Genetics Consortium
PLoS One; 2011 Apr; 6(4):e18813. PubMed ID: 21552549
[TBL] [Abstract][Full Text] [Related]
11. Critical Role of CD6highCD4+ T Cells in Driving Th1/Th17 Cell Immune Responses and Mucosal Inflammation in IBD.
Ma C; Wu W; Lin R; Ge Y; Zhang C; Sun S; Cong Y; Li X; Liu Z
J Crohns Colitis; 2019 Mar; 13(4):510-524. PubMed ID: 30395204
[TBL] [Abstract][Full Text] [Related]
12. High CD6 and low chemokine receptor expression on peripheral blood lymphocytes correlates with MRI gadolinium enhancement in MS.
Jurewicz A; Zaleski K; Domowicz M; Selmaj K
J Neuroimmunol; 2014 Nov; 276(1-2):187-94. PubMed ID: 25242631
[TBL] [Abstract][Full Text] [Related]
13. Identification of residues in CD6 which are critical for ligand binding.
Bodian DL; Skonier JE; Bowen MA; Neubauer M; Siadak AW; Aruffo A; Bajorath J
Biochemistry; 1997 Mar; 36(9):2637-41. PubMed ID: 9054570
[TBL] [Abstract][Full Text] [Related]
14. The CD6 scavenger receptor is differentially expressed on a CD56 natural killer cell subpopulation and contributes to natural killer-derived cytokine and chemokine secretion.
Braun M; Müller B; ter Meer D; Raffegerst S; Simm B; Wilde S; Spranger S; Ellwart J; Mosetter B; Umansky L; Lerchl T; Schendel DJ; Falk CS
J Innate Immun; 2011; 3(4):420-34. PubMed ID: 21178331
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the CD6 ligand binding domain.
Skonier JE; Bodian DL; Emswiler J; Bowen MA; Aruffo A; Bajorath J
Protein Eng; 1997 Aug; 10(8):943-7. PubMed ID: 9415444
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis associated genetic variants of CD226 impair regulatory T cell function.
Piédavent-Salomon M; Willing A; Engler JB; Steinbach K; Bauer S; Eggert B; Ufer F; Kursawe N; Wehrmann S; Jäger J; Reinhardt S; Friese MA
Brain; 2015 Nov; 138(Pt 11):3263-74. PubMed ID: 26359290
[TBL] [Abstract][Full Text] [Related]
17. Discrimination of different subsets of cytolytic cells in pseudorabies virus-immune and naive pigs.
de Bruin TG; van Rooij EM; de Visser YE; Voermans JJ; Samsom JN; Kimman TG; Bianchi AT
J Gen Virol; 2000 Jun; 81(Pt 6):1529-37. PubMed ID: 10811936
[TBL] [Abstract][Full Text] [Related]
18. CD6 modulates thymocyte selection and peripheral T cell homeostasis.
Orta-Mascaró M; Consuegra-Fernández M; Carreras E; Roncagalli R; Carreras-Sureda A; Alvarez P; Girard L; Simões I; Martínez-Florensa M; Aranda F; Merino R; Martínez VG; Vicente R; Merino J; Sarukhan A; Malissen M; Malissen B; Lozano F
J Exp Med; 2016 Jul; 213(8):1387-97. PubMed ID: 27377588
[TBL] [Abstract][Full Text] [Related]
19. CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction.
Nair P; Melarkode R; Rajkumar D; Montero E
Clin Exp Immunol; 2010 Oct; 162(1):116-30. PubMed ID: 20726988
[TBL] [Abstract][Full Text] [Related]
20. Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.
Casadó-Llombart S; Ajami T; Consuegra-Fernández M; Carreras E; Aranda F; Armiger N; Alcaraz A; Mengual L; Lozano F
Prostate; 2022 Oct; 82(14):1331-1337. PubMed ID: 35767366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
